Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Wounded by Gunfire, Ukranians Airlifted to Hadassah

Although Oleksandr Huch and Arten Zapototskyi did not know each other in their homeland of Ukraine, today they are roommates on the fifth floor of the Hadassah Medical Organization's Sarah Wetsman Davidson Hospital Tower.

Thanks to the help of private donors and volunteers, the two men were airlifted to Israel to be treated for the gunshot wounds they sustained while taking part in the Kiev demonstrations. Mr. Huch, an athlete and teacher in a teen sports center, was helping a wounded friend when a bullet passed through his upper leg. Mr. Zapototskyi, a corporate lawyer and father of two, took a bullet in his lung and his spine. Medical teams in the nearby countries of Germany and Austria declined to take the two men. Said a coordinator from the Ukraine, "They all knew that Israel had more experience with gunshot wounds."

Kiev's medical team, struggling to cope with Mr. Huch's open wound and complex fracture, had decided his left leg would need to be amputated when the possibility of bringing him to Israel was raised.

A facebook campaign, "Save Zapototskyi," asked for ideas about what could be done for him. Sending him to Hadassah kept coming up as a suggestion. "I'm grateful to be here," Mr. Zapototskyi says.

Mr. Zapototskyi had come to Kiev out of a compelling sense of civic duty. "I don't want to talk about the politics of the demonstrations," he said. "I want to concentrate on getting well." Tears well up as he looks at the photos of his wife and small children.

Spine specialist Prof. Leonid Kaplan, whose first language is Russian, is caring for Mr. Zapototskyi. Having decided against surgery, he plans to send his patient to the physical therapy department at Hadassah-Mount Scopus. Senior Orthopedic Surgeon Dr. Amal Khoury is treating Mr. Huch. "He has a complex condition because he came to us with a serious infection," Dr. Khoury relates, "but I have no doubt that he will overcome it, recover fully, and regain his life and livelihood."

Read about it in The Jerusalem Post

Date: 3/12/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America